Harlequin Fetus
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Harlequin type ichthyosis
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Influenza
|
0.010 |
Biomarker
|
disease |
BEFREE |
Influenza virus RNA polymerase (RdRp) PB2 is the cap-1 binding subunit and determines host range and pathogenicity.
|
22146492 |
2012 |
Cholera
|
0.010 |
Biomarker
|
disease |
BEFREE |
CAP-1 displayed a broad antimicrobial spectrum against the indicator bacteria and fungus, including Staphylococcus aureus, Escherichia coli, Bacillus subtilis and Candida albicans, especially some marine-derived microorganisms such as Vibrio vulnificus, Vibrio alginolyticus, Vibrio parahaemolyticus, Vibrio cholera, and Vibrio anguillarum, but showed little impact on tumor cells and normal human cells.
|
26529191 |
2016 |
Neoplasms
|
0.080 |
AlteredExpression
|
group |
BEFREE |
PRSS8 expression profiles stratified by OVC tumor stage-, grade- and subtype were generated using cDNA samples from 159 OVC samples.
|
27036110 |
2016 |
Squamous cell carcinoma of esophagus
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
PRSS8 methylation and its significance in esophageal squamous cell carcinoma.
|
27081034 |
2016 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
PRSS8 is Downregulated and Suppresses Tumour Growth and Metastases in Hepatocellular Carcinoma.
|
27915333 |
2016 |
Secondary Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
PRSS8 is Downregulated and Suppresses Tumour Growth and Metastases in Hepatocellular Carcinoma.
|
27915333 |
2016 |
Malignant Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Protease serine 8 (PRSS8), a trypsin-like serine peptidase, has been shown to function as a tumour suppressor in various malignancies.
|
27915333 |
2016 |
Tumor Cell Invasion
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
PRSS8 upregulation inhibited glioma cell proliferation, migration, and invasion.
|
27983922 |
2017 |
TARSAL-CARPAL COALITION SYNDROME
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A panel of 16 urothelial and TCC cell lines were evaluated for prostasin and E-cadherin expression by western blot and quantitative PCR, and for prostasin gene promoter region CpG methylation by methylation-specific PCR (MSP).
|
19849847 |
2009 |
Hyperaldosteronism
|
0.010 |
Biomarker
|
disease |
BEFREE |
Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats.
|
12626364 |
2003 |
Hypertensive disease
|
0.020 |
Biomarker
|
group |
BEFREE |
Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats.
|
12626364 |
2003 |
Malignant neoplasm of prostate
|
0.310 |
Biomarker
|
disease |
CTD_human |
Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG.
|
16541421 |
2006 |
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG.
|
16541421 |
2006 |
Essential Hypertension
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association of genetic variations of the prostasin gene with essential hypertension in the Xinjiang Kazakh population.
|
21933610 |
2011 |
Malignant Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
De-methylation agent decitabine was able to restore PRSS8 expression, leading to the inhibition of cancer cell proliferation, motility, migration and cell cycle arrest.
|
27081034 |
2016 |
Primary malignant neoplasm
|
0.030 |
AlteredExpression
|
group |
BEFREE |
De-methylation agent decitabine was able to restore PRSS8 expression, leading to the inhibition of cancer cell proliferation, motility, migration and cell cycle arrest.
|
27081034 |
2016 |
Neoplasms
|
0.080 |
AlteredExpression
|
group |
BEFREE |
Ectopic expression of PRSS8 inhibited tumor growth in vitro and in vivo.
|
27983914 |
2017 |
Diastematomyelia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |
Neural Tube Defects
|
0.300 |
Therapeutic
|
group |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |
Neurenteric Cyst
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |
Placenta Disorders
|
0.300 |
Therapeutic
|
group |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |
Tethered Cord Syndrome
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |
Iniencephaly
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.
|
24722141 |
2014 |